<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2983306R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3565</journal-id>
<journal-id journal-id-type="nlm-ta">Epilepsia</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia</journal-id>
<journal-title-group>
<journal-title>Epilepsia</journal-title>
</journal-title-group>
<issn pub-type="ppub">0013-9580</issn>
<issn pub-type="epub">1528-1167</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31087664</article-id>
<article-id pub-id-type="pmc">6880653</article-id>
<article-id pub-id-type="doi">10.1111/epi.15160</article-id>
<article-id pub-id-type="manuscript">NIHMS1056920</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular Basis for and chemogenetic Rescue of Comorbidities in <italic>GABRG2</italic>-Deficient Epilepsies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Chun-Qing</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McMahon</surname>
<given-names>Bryan</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Huancheng</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Warner</surname>
<given-names>Timothy</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Wangzhen</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gallagher</surname>
<given-names>Martin</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Macdonald</surname>
<given-names>Robert L.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Jing-Qiong</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Departments of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A2"><label>2</label>Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A3"><label>3</label>Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A4"><label>4</label>Vanderbilt Brain Institute, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P43"><bold>Author Contribution:</bold> CQZ performed brain slice patch-clamp recordings and set the protocol for dissecting the central nucleus of the amygdala. BM performed immunohistochemistry, HCD and TAW performed viral injections and behavioral tests. WS conducted biochemistry experiments. MJG provide consultation on chemogenetic study. RLM edited the paper and supported the research. JQK conceived the project, designed the study, analyzed data, performed imaging studies and wrote the manuscript. All authors reviewed the manuscript.</p>
</fn>
<corresp id="CR1"><bold>Corresponding Author</bold>: Jing-Qiong Kang, M.D., Ph.D., Vanderbilt University Medical Center, 6140 Medical Research Building III, 465 21st Ave, South, Nashville, TN 37232-8552, Tel: 615-936-8399; fax: 615-322-5517, <email>jingqiong.kang@vanderbilt.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P45"><bold>Conflict of Interest statement</bold>: None of authors declared any conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>60</volume>
<issue>6</issue>
<fpage>1137</fpage>
<lpage>1149</lpage>
<!--elocation-id from pubmed: 10.1111/epi.15160-->
<abstract id="ABS1">
<sec id="S1">
<title>Summary</title>
</sec>
<sec id="S2">
<title>Objective:</title>
<p id="P1">GABA<sub>A</sub> receptor subunit gene mutations are significant causes of epilepsy, which are often accompanied with various neuropsychiatric comorbidities, but the underlying mechanisms are unclear. It has been suggested that the comorbidities are caused by seizures as they often present in severe epilepsies. However, findings from both humans and animal models argue against this conclusion. Mutations in the GABA<sub>A</sub> receptor γ2 subunit gene <italic>GABRG2</italic> have been associated with anxiety alone or with severe epilepsy syndromes and comorbid anxiety, suggesting a core molecular defect gives rise to the phenotypical spectrum. Here we determined the pathophysiology of comorbid anxiety in epilepsy and identified the central nucleus of the amygdala (CeA) as a primary neurosubstrate and a potential rescue via neuromodulation of CeA neurons.</p>
</sec>
<sec id="S3">
<title>Methods:</title>
<p id="P2">We used brain slice recordings, subcellular fractionation and western blot, immunohistochemistry, confocal microscopy and a battery of behavior tests in combination with a chemogenetic approach to characterize anxiety and its underlying mechanisms in a <italic>Gabrg2</italic><sup><italic>+/Q390X</italic></sup> knockin mouse and a <italic>Gabrg2</italic><sup><italic>+/−</italic></sup> knockout mouse, each associated with a different epilepsy syndrome.</p>
</sec>
<sec id="S4">
<title>Results:</title>
<p id="P3">We found that impaired GABAergic neurotransmission in CeA underlies anxiety in epilepsy, which is due to reduced GABA<sub>A</sub> receptor subunit expression resulting from the mutations. Impaired GABA<sub>A</sub> receptor expression reduced GABAergic neurotransmission in CeA, but not in BLA. Activation or inactivation of inhibitory neurons using a chemogenetic approach in CeA alone modulated anxiety-like behaviors. Similarly, pharmacological enhancement of GABAergic signaling via γ2 subunit-containing receptors rescued the anxiety.</p>
</sec>
<sec id="S5">
<title>Significance:</title>
<p id="P4">Together, these data demonstrate the molecular basis for a comorbidity of epilepsy and suggest that impaired GABA<sub>A</sub> receptor function in CeA due to mutation per se could at least contribute to anxiety. Modulation of CeA neurons could cause or suppress anxiety, suggesting a potential use of CeA neurons as therapeutic targets for treatment of anxiety in addition to traditional pharmacological approaches.</p>
</sec>
</abstract>
<kwd-group>
<kwd>GABA<sub>A</sub> receptors</kwd>
<kwd>epilepsy</kwd>
<kwd>anxiety</kwd>
<kwd>amygdala</kwd>
<kwd>comorbidity</kwd>
<kwd>chemogenetic</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>